(Left to Right: Susan Geyer, Carolyn Mead-Harvey, and Dr. Amylou Dueck) The Mayo Clinic group from the MPN Research Consortium attended the American Society of Hematology 2024 Conference in San Diego, California from December 7th - 10th.

Dr. Shivani Handa presents her ASH abstract “243 TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms”. View the abstract here!

Dr. Anna Rita Migliaccio asking after the talk at the plenary session on megakaryocytes in the elderly whether the GATA1low megakaryocytes which are enriched in the elderly represent an enrichment in the immune-megakaryocte subpopulations.